These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2112415)

  • 1. Double negative (CD4/CD8) T cell receptor alpha/beta positive lymphocytes in patients with graft-versus-host disease.
    Klingemann HG; Phillips GL
    Bone Marrow Transplant; 1990 May; 5(5):364. PubMed ID: 2112415
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-negative (CD4- CD8-) T cells with an alpha/beta T cell receptor. Non-MHC-restricted cytolytic activity and lymphokine production.
    Brooks EG; Wirt DP; Goldblum RM; Vaidya S; Asuncion MT; Patterson JC; Ware CF; Klimpel GR
    J Immunol; 1990 Jun; 144(12):4507-12. PubMed ID: 2141037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.
    Scott CS; Richards SJ; Roberts BE
    Immunology; 1990 Jul; 70(3):351-6. PubMed ID: 2143170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
    Shivakumar S; Tsokos GC; Datta SK
    J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selective depletion of donor CD8+ lymphocytes on graft-versus-host disease in small-bowel transplantation.
    Deaton DH; Barker CF; Naji A
    Transplant Proc; 1990 Dec; 22(6):2467-8. PubMed ID: 2124740
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells.
    Caillat-Zucman S; Blumenfeld N; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplantation; 1990 Jan; 49(1):156-60. PubMed ID: 2137271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverted ratio of CD4/aB heterodimer T cell antigen receptor (TCR aB) to CD8/TCR aB on sorted Leu-7+ (HNK-1) lymphocyte subset in long-term renal allograft recipients.
    Rodriguez SG; Guttmann RD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):257-8. PubMed ID: 2495603
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
    Rivas A; Koide J; Laus R; Engleman EG
    J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.
    Atkinson K; Cooley M; Farrelly H; O'Flaherty E; Ashby M; Biggs J
    Bone Marrow Transplant; 1987 Jun; 2(1):79-84. PubMed ID: 2901876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection.
    Berg LJ; Fazekas de St Groth B; Pullen AM; Davis MM
    Nature; 1989 Aug; 340(6234):559-62. PubMed ID: 2528070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin, differentiation, and repertoire selection of CD3+CD4-CD8- thymocytes bearing either alpha beta or gamma delta T cell receptors.
    Suda T; Zlotnik A
    J Immunol; 1993 Jan; 150(2):447-55. PubMed ID: 8419477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.